tm logo

Monitor this mark

View On USPTO

LAMIRA
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 16 Nov 2024

Last Applicant/ Owned by

PARI Pharma GmbH

Moosstrasse 3

Starnberg

DE

82319

Serial Number

86619954 filed on 05th May 2015

Registration Number

5638220 registered on 25th Dec 2018

in the Principal Register

Correspondent Address

Robin C. Vance

Robin C. Vance MCGUIREWOODS LLP

800 EAST CANAL STREET

RICHMOND, VA 23219-3916

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

LAMIRA

Medical devices for application of substances into the lungs, namely, nebulizers, inhalers, compressors used in the treatment of respiratory diseases

Classification Information

Class [010]
Medical Instrument Products

Medical devices for application of substances into the lungs, namely, nebulizers, inhalers, compressors used in the treatment of respiratory diseases

First Use Date in General

05th Nov 2018

First Use Date in Commerce

05th Nov 2018

Mark Details

Serial Number

No 86619954

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 2008207-1024

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
16th Nov 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
16th Nov 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
16th Nov 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04th Jun 2024TEAS SECTION 8 & 15 RECEIVED
25th Dec 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
25th Dec 2018REGISTERED-PRINCIPAL REGISTER
17th Nov 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16th Nov 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Nov 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15th Nov 2018STATEMENT OF USE PROCESSING COMPLETE